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The criteria employed for Korean Beh et’ s disease (BD) from January 1990 to
December 2000 have been investigated, and the diagnostic validity for those criteria
was determined. For the generation of a modified set of preliminary criteria from
the International Study Group (ISG) criteria, the diagnostic values for individual fea-
ture of BD were calculated. The criteria by the Beh et’ s Disease Research Com-
mittee of Japan appeared to be widely employed with the ISG criteria. However,
because the ISG criteria revealed a relatively valid outcome in Korea, the appli-
cation of this criteria will be needed for the universal unification until the criteria
with better performance comes out. On the other hand, the modified set of prelimi-
nary criteria that consisted of the clinical items with better results seemed to improve
some pitfalls of the ISG criteria. Although that criteria showed better performance
than the preexisting criteria, it should be necessary to validate its effectiveness
in other areas. 
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INTRODUCTION
Beh et’ s disease (BD) is a chronic inflammatory multisys-
temic disorder with unknown etiology. Because the patho-
gnomonic clinical features and tools are absent, the diagno-
sis of BD mainly relies on the characteristic clinical features
and the judgement of the experienced physician. Before the
introduction of the International Study Group (ISG) criteria
(1), several sets of classification or diagnosis criteria had
widely been employed (2-5), which had interfered with the
comparison or collaboration of the clinical studies between
centers or countries. Therefore, the ISG criteria was developed
to ensure the uniformities of patients in the clinical studies,
rather than the diagnosis of the individual case (6). 
In spite of the internationally agreed criteria, the ones used
in Korea for the clinical studies of BD still have not been uni-
fied. In addition, this country had not taken part in the orig-
inal survey for the ISG criteria. Even though this criteria has
shown the relatively valid performance in different regions
(7-10), some problems have been raised. Although patients
with BD in the original survey for the ISG criteria were recruit-
ed from the 12 centers in 7 countries, most patients (86.7%)
were derived from the countries with high positive rate of the
pathergy reaction (PR) such as Iran, Turkey, and Japan (6),
and the sensitivity of that criteria could be low in the ethnic
areas where the positive PR is less prevalent (8). Another prob-
lem is that the ISG criteria may not classify or diagnose acute
cases without recurrent oral ulcerations (ROUs) over 3 times
in a 1-yr, patients who do not have the oral ulcerations, or pa-
tients in whom the oral ulcerations manifest later (8, 11, 12).
Therefore, this study was undertaken to investigate the cri-
teria for BD commonly used in Korea after the introduction
of the ISG criteria, to assess the diagnostic validity for those
criteria, and to propose a modified set of preliminary criteria
with better performance from the ISG criteria.
MATERIALS AND METHODS
From January 1990 to December 2000, the criteria applied
to the clinical studies for Korean patients with BD have been
investigated with the exception of review articles or case re-
ports.
Seventy unselected patients with BD were recruited at a
tertiary referral center from March 1997 to March 2001, in
whom the diagnosis was established by a rheumatologist famil-
iar with BD. Patients with only orogenital ulceration were
excluded. In addition, 70 patients, matched age and sex, whoThe Criteria for Beh et’ s Disease  89
had similar features to BD (diagnoses based on internationally
accepted criteria) or recurrent aphthous stomatitis were studied
as controls. Patients with BD and controls were ethnically
homogenous Koreans.
Detailed data on the presence or absence of the clinical fea-
tures of BD in each individual with BD or controls were pro-
spectively recorded on a standard form and were entered into
a computer database. The sensitivity, specificity, and accuracy
for the criteria commonly used in Korea were determined:
sensitivity is defined as the proportion of subjects with the
disease who have a positive test result, specificity is the pro-
portion of subjects without the disease who have a negative
test result, and accuracy is the proportion of all test results,
both positive and negative, which are correct. For the genera-
tion of a modified set of preliminary criteria, the log-likelihood
ratio and the expected weight of evidence for the individual
clinical feature of BD were calculated with the same method
that the ISG criteria was formulated (6, 13).
RESULTS
Fifty-seven clinical articles for BD have been published dur-
ing the investigated period in Korea. Among these studies,
51 papers have employed 59 criteria of BD, while the remain-
ing 6 have not made mention of the criteria. Thirty-four arti-
cles have used the criteria by the Beh et’ s Disease Research
Committee of Japan (Japanese criteria) (2, 14), 21 by the ISG,
and 4 by others, of which 3 employed Lehner and Barnes (15)
and 1 Mason and Barnes (3). Among the articles that have
used the Japanese criteria, 18 included all types, such as com-
plete, incomplete, suspected, and possible types, for the clas-
sification or diagnosis of BD in their clinical studies. Twelve
comprised the other 3 types except for the possible type and
the remaining 4 comprised only two types, the complete and
incomplete types. The ISG criteria were first employed in 1994
in Korea (16), and although this criteria has been increasingly
used year after year, the Japanese criteria has still been pop-
ularly adopted (Fig. 1).
There were no differences of the demographic findings bet-
ween patients with BD and controls (Table 1). The diagnoses
of patients in the controls were presented Table 2, and these
were similar to controls of other studies (1, 8). However, pa-
tients with inflammatory bowel diseases who might be dif-
ficult to be differentiated from BD were supplemented in the
controls of the current study.
Table 3 showed sensitivity and specificity, log-likelihood
ratio, and the expected weight of evidence of each clinical fea-
ture in patients with BD. As for the expected weight of evi-
dence, genital ulcerations revealed the greatest value, and skin
lesions, PR, ROUs, HLA-B51, ocular lesions, and ileocecal
ulcerations in order showed the relatively good performance.
However, other features, such as CNS lesions, vascular lesions,
peripheral arthritis, and epididymitis, disclosed negligible val-
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Fig. 1. The annual trend of the criteria recently used in Korea. ISG:
Number of articles using the criteria by the International Study Group.
Japanese: Number of articles using the criteria by the Beh et’s
Disease Research Committee of Japan.
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ISG
Japanese
Sex (female %) 68.6 65.7
Age (yr) (mean±SD) 39.1±10.2 38.6±13.0
Disease duration [yr, mean (range)] 5.7 (0.5-40) 5.5 (0.6-37)
Table 1. The demographic findings of patients with Beh et’ s dis-
ease and controls
Behcet disease
(n=70)
Control
(n=70)
Systemic lupus erythematosus 20 (28.6)
Spondylarthropathy 16 (22.9)
Sj gren syndrome 12 (17.1)
Ulcerative colitis 8 (11.4)
Crohn’s disease 1 (1.4)
Recurrent aphthous stomatitis 13 (18.6)
Diagnosis Number (%)
Table 2. The diagnoses of patients in the controls
Genital ulcers 77.1 98.6 40.1 -14.6 34.2
Skin lesions 85.7 74.3 12.0 -16.5 12.7
Pathergy reaction 34.3 97.1 24.7 -3.9 11.1
Recurrent oral ulcers 97.1 57.1 8.2 -29.8 8.9
HLA-B51 50.0 83.3 11.0 -5.1 8.1
Ocular lesions 21.4 95.7 16.0 -2.0 5.1
Ileocecal ulcers 15.7 98.6 24.2 -1.6 5.1
CNS lesions 4.3 97.1 3.9 -0.1 0.3
Vascular lesions 5.7 95.7 2.8 -0.1 0.3
Peripheral arthritis 22.9 75.7 -0.6 0.2 0
Epididymitis 2.9 98.6 7.3 -0.2 0.4
Table 3. The measures of sensitivity, specificity, log-likelihood ratio
and the expected weight of evidence of each clinical feature of Beh et’ s
disease
Log-likelihood ratio
Feature Feature Expected
Features Sensitivity Specificity present absent weight of
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ues. A modified set of preliminary criteria for the classification
or diagnosis of BD was established by the clinical features with
better results. The genital ulcerations were weighed by the
score of 2, and the remaining features were given with the score
of 1 with the exception of HLA-B51 not being a clinical fea-
ture, showing a lot of the geographic variation (17). HLA-B51
was separately set as a finding to help for classification or diag-
nosis. BD could be classified or diagnosed if the score is over 3
(Table 4).
Table 5 depicted sensitivity, specificity and accuracy of the
three sets of criteria such as the ISG criteria, the Japanese cri-
teria, and the modified set of preliminary criteria, in which the
modified criteria revealed the best performance with the accu-
racy of 97.1%. 
DISCUSSION
After the introduction of the ISG criteria, it appeared that
the Japanese criteria has still been widely employed, together
with the ISG criteria in Korea. Moreover, most studies to adopt
the Japanese criteria have included possible type or suspect-
ed type, the potential disease entity rather than the definitive
diagnosis of BD, which has not only limited the comparative
studies or epidemiological research between centers or areas,
but also caused the bias of their results. Because the ISG cri-
teria has revealed a valid performance in Korea, the application
of this criteria in the clinical studies of BD will be needed
for the universal unification from now on until the criteria
with better performance comes out.
The reasons that the Japanese criteria had a lower diagnos-
tic value when compared to the ISG criteria in present study
may be as follows. First, some clinical features such as CNS
lesions, vascular lesions, peripheral arthritis, and epididymitis
among minor criteria of the Japanese criteria were uncommon
in our series. Second, the Japanese criteria could not classify
or diagnose patients with ROUs, skin lesions, and a positive
PR, who were classified into suspected type. 
The prevalence of a positive PR varies according to countries
or investigators. The high positive rate of PR has been des-
cribed in some ethnic areas such as Turkey, Iran, and Japan
(18-20), but this was not the case in other countries (21, 22).
Furthermore, after the introduction of a disposable needle,
the prevalence and intensity of a positive PR in patients with
BD have been described to decrease (23). In the original sur-
vey for the ISG criteria, most patients with BD were recruit-
ed from the areas with a high positive rate of PR, and the PR
has become one of the major criteria. Therefore the sensitivity
of such criteria could be low in the areas where a positive PR
is uncommon. On the other hand, patients with only orogen-
ital ulcerations, of whom most patients may be considered
to have a mild BD, do not meet the ISG criteria. If the sensitiv-
ity of a positive PR would be greater, a considerable portion of
those patients might be classified or diagnosed as BD. Because
of the exclusion of patients with only orogenital ulcerations,
the diagnostic value of the ISG criteria and the Japanese cri-
teria may be speculated to be higher in the current study.
Although the ISG have considered the ROUs to be a ‘con-
ditio sine qua non’ for the classification or diagnosis of BD,
3% of patients with definitive BD in whom the oral ulcera-
tions did not manifest were excluded in the original survey (1).
Whereas the ROUs have been the most common and impor-
tant clinical feature, a sizable portion of patients have initially
manifested without ROUs with variable rate of 13.5-27%
(24-27). In addition, other authors pointed out that the ISG
criteria could not classify or diagnose acute cases with severe
disease without ROUs over 3 times in a 1-yr, which may delay
a proper diagnosis and the prompt initiation of treatment (11,
12, 28). If the sensitivity and specificity of the designated cri-
teria were very high, a classification criteria could be used as
a diagnostic criteria, and would apply to every individual case
(29-31). Therefore, in the classification or diagnosis of BD,
the criteria with better performance to settle the suggested
problems may be necessary.
International Study Group 91.4 97.1 94.3
Japanese 85.7 95.7 90.7
New preliminary criteria 97.1 97.1 97.1
Criteria Sensitivity (%) Specificity (%) Accuracy (%)
Table 5. The sensitivity, the specificity, and the accuracy of each
criteria
1. Recurrent genital ulcerations 2
Painful aphthous ulceration or scarring confidently
detected by physician or patient
The exclusion of genital ulcerations associated with
herpes genitalis, chancre, or chancroid
2. Recurrent oral ulcerations 1
Painful aphthous ulceration confidently detected by
physician or patient
3. Skin lesions 1
a) Erythema nodosum-like lesions confidently
detected by physician or patient
b) Pseudofollicullitis or papulopustular lesions only
detected by physician with the exception of lesions
related with puberty or corticosteroid therapy
4. Ocular lesions 1
Anterior uveitis, posterior uveitis or retinal vasculitis
diagnosed by ophthalmologist
5. Pathergy reaction 1
Papule or pustule observed by physician at 48 hr, done by 
intradermal prick with 20-22 gauge disposable needle
6. Ileocecal ulcerations 1
The exclusion of inflammatory bowel disease or
intestinal tuberculosis
Beh et’s disease can be classified or diagnosed if the score is more
than 3. *Finding helpful for diagnosis or classification: HLA-B51
Clinical Features Score
Table 4. A suggested preliminary criteriaThe Criteria for Beh et’ s Disease  91
Although our preliminary criteria is in some degree derived
from the ISG criteria, there are a few differences between these
two criteria. First of all, with reference to the expected weight
of evidence, the diagnostic power of the genital ulcerations
is doubled when compared to other clinical items. Consequent-
ly, the classification or diagnosis of BD could be established
by genital ulcerations plus one more other clinical items. How-
ever, the genital ulcerations by other causes such as sexually
transmitted diseases (genital herpes, chancer, chancroid) should
be ruled out. Second, the ROUs are not a  ‘conditio sine qua
non’ in our criteria. Moreover, as the frequency (over 3 times
in a 1-yr) of them is deleted, the classification or diagnosis
of BD could be made even in cases without ROUs or in acute
patients that there are not ROUs over 3 times in a 1-yr. Third,
the ileocecal ulcerations, one of the serious clinical manifes-
tations, are added with the exclusion of those by other caus-
es such as inflammatory bowel disease and intestinal tuber-
culosis.
Similarly to our study, the genital ulcerations also showed
the greatest diagnostic value in the original study by the ISG
(1). As the clinical features of genital ulcerations in BD are
quite typical, these lesions can be detectable by an experienced
physician through a careful history taking and physical exam-
ination. They usually occur on the scrotum and penis in men
and on the vulva in women. Genital ulcers resemble oral ulcers
but are often larger and deeper, and are more painful and last
longer. They often leave scars and recurrences occur less fre-
quently than oral ulcers (19, 20). However, besides the genital
ulcerations of BD, there are other causes of genital ulcerations
such as sexually transmitted diseases. A clinical diagnosis of
genital herpes can be made if typical painful, grouped vesicles
or pustules are preceded by a prodrome of stinging or burn-
ing. Primary syphilis (chancer) may be easily differentiated
from those of BD because this disease has painless, nontender,
indurated ulcers frequently accompanied with firm, nontender
inguinal adenopathy. Chancroid, another cause of genital ul-
ceration, has a painful ulcer with ragged, undermined borders
and associated tender inguinal lymphadenitis. Nevertheless,
because some genital ulcerations cannot be diagnosed confi-
dently on clinical grounds alone, the following examinations
may be needed: dark-field examination or serologic tests for
Treponema pallidum, serologic tests for Herpes simplex virus, and
culture or PCR tests for Haemophilus ducrei (32).
Because the prevalence of some clinical features of BD dif-
fers according to areas or countries (19), it may be difficult to
make the criteria that embrace all patients with BD in the
different areas of the world. For example, the ileocecal ulcera-
tions relatively prevalent in our series and in Japan (20) have
been rarely described in Turkey (33). Therefore, even though
our preliminary criteria may improve the classification or
diagnosis of patients with the intestinal ulcerations, it would
be not the case in Turkey. However, this problem might be
overcome with an emphasis of the clinical significance of the
genital ulcerations. Conclusively, our preliminary criteria may
not only classify or diagnose a mild BD patients with only
orogenital ulcerations, patients without ROUs, or acute cases
without ROUs over 3 times in a 1-yr, but also increase the
sensitivity for the classification or diagnosis of BD in the eth-
nic areas with low positive rate of the PR. Although our cri-
teria showed greater performance when compared with the
existing two criteria in the current study, it should be neces-
sary to validate its effectiveness for patients in other clinics or
countries, because the number of patients with BD was small
and the validation sample of patients like the original survey
by the ISG (6) was lacking in the present study. The validation
assay in several centers of the different areas of Korea is going
to be under way.
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